• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Caplin Point Laboratories Limited — Important, 01-01-2026: Updates

    01-01-2026 | 11:34 am

    Caplin Point, via its subsidiaries, acquired 10 approved Injectable & Ophthalmic ANDAs from a multinational firm. This strategically boosts its US portfolio, addressing a $473.2 million market, and includes oncology injectables for its new facility, with plans for international expansion.

    No comments yet. Be the first to comment!

    All announcements from Caplin Point Laboratories Limited